ID   GHOST(3).CCR3
AC   CVCL_S490
SY   GHOST (3) CCR3; GHOST cell CCR3; GHOST (3) CCR3+
DR   cancercelllines; CVCL_S490
DR   HIVReagentProgram; ARP-3682
DR   Wikidata; Q54835788
RX   PubMed=11878871;
RX   PubMed=16061987;
WW   http://www.nibsc.org/Default.aspx?pageid=597&ID=0076
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: UniProtKB; P42212; GFP.
CC   Transfected with: HGNC; 1604; CCR3.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 15
//
RX   PubMed=11878871; DOI=10.1006/viro.2001.1163;
RA   Vodros D., Tscherning-Casper C., Navea L., Schols D., De Clercq E.,
RA   Fenyo E.-M.;
RT   "Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell
RT   assay.";
RL   Virology 291:1-11(2001).
//
RX   PubMed=16061987; DOI=10.1385/1-59259-907-9:333;
RA   Vodros D., Fenyo E.-M.;
RT   "Quantitative evaluation of HIV and SIV co-receptor use with GHOST(3)
RT   cell assay.";
RL   Methods Mol. Biol. 304:333-342(2005).
//